Back to Search
LAPO ALINARI, M.D., PHD
M.D., PHD
Hematology (Internal Medicine) Physician
NPI: 1356634455IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology (Internal Medicine) PhysicianPrimary
Internal Medicine — Hematology
Code: 207RH0000X
35.122337(OH)
CMS Specialties
PrimaryHEMATOLOGY
Education
OTHER
Class of 1998
Research & Publications (20)
Alemtuzumab (Campath-1H) in the treatment of chronic lymphocytic leukemia.
PMID 17530018·Oncogene·2007
6-review
Enhancement of TRAIL cytotoxicity by AG-490 in human ALL cells is characterized by downregulation of cIAP-1 and cIAP-2 through inhibition of Jak2/Stat3.
PMID 19564891·Cell Res·2009
8-other
Role of [18F]fluorodeoxyglucose positron emission tomography scan in the follow-up of lymphoma.
PMID 19273712·J Clin Oncol·2009
3-trial
A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients.
PMID 18303033·Ann Oncol·2008
3-trial
Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B-cell non-Hodgkin lymphoma.
PMID 18833583·Cancer·2008
3-trial
Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma.
PMID 17709797·J Clin Oncol·2007
3-trial
Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphoma.
PMID 17550849·Haematologica·2007
4-observational
VNCOP-B plus rituximab in the treatment of diffuse large B-cell lymphoma in the elderly.
PMID 17990178·Leuk Lymphoma·2007
3-trial
Predictive role of positron emission tomography in the outcome of patients with follicular lymphoma.
PMID 17324337·Clin Lymphoma Myeloma·2007
8-other
Discordant response to chemotherapy: an unusual pattern of fluoro-deoxy-D-glucose uptake in heavily pre-treated lymphoma patients.
PMID 16840196·Leuk Lymphoma·2006
8-other
Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patients.
PMID 16766583·Ann Oncol·2006
8-other
18F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma.
PMID 17071482·Leuk Lymphoma·2006
8-other
Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas.
PMID 16492713·J Clin Oncol·2006
4-observational
Potential pitfalls of 18F-FDG PET in a large series of patients treated for malignant lymphoma: prevalence and scan interpretation.
PMID 16000986·Nucl Med Commun·2005
8-other
Phase II trial of temozolomide in patients with pretreated cutaneous T-cell lymphoma.
PMID 16154858·Haematologica·2005
3-trial
Role of anemia in survival of patients with elderly aggressive non-Hodgkin's lymphoma after chemotherapy.
PMID 16194890·Leuk Lymphoma·2005
8-other
Gemcitabine as frontline treatment for cutaneous T-cell lymphoma: phase II study of 32 patients.
PMID 16216001·Cancer·2005
3-trial
Value of oxaliplatin treatment in heavily pretreated patients with non-Hodgkin's lymphoma.
PMID 16252433·Leuk Lymphoma·2005
3-trial
Efficacy and safety of oral fludarabine/cyclophosphamide regimen in previously treated indolent lymphomas.
PMID 16263591·Leuk Lymphoma·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 460 W 10TH AVE
COLUMBUS, OH 43210 - Phone
- (614) 293-3196
Quick Facts
- NPI
- 1356634455
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 28
- Publications
- 20
Are you this provider?
Claim Your Profile